NRXP 10-Q: SEC filing
NRX Pharmaceuticals
Filed with the SEC on · accession 0001437749-26-037198
NRXP filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. NRX Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a net loss and continued ATM and underwritten equity offerings. The stock moved -1.8% by the first close after the filing.
Summary of the filing
NRX Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a net loss and continued ATM and underwritten equity offerings. The filing reflects ongoing operational losses and financing activities typical of a clinical-stage biopharmaceutical company.
Key details
How NRXP stock reacted
Close before
$2.19
Nov 13, 2026
First close after
-1.83%
$2.15
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NRXP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NRXP?
Click hereFrequently asked questions
What did NRXP file with the SEC on Nov 16, 2026?
NRXP filed a 10-Q (SEC filing). NRX Pharmaceuticals filed its Q3 2026 Form 10-Q, reporting quarterly financial results including a net loss and continued ATM and underwritten equity offerings. The filing reflects ongoing operational losses and financing activities typical of a clinical-stage biopharmaceutical company.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did NRXP stock react to this filing?
NRXP closed at $2.19 before the filing and $2.15 on Nov 16, 2026 (-1.83%).
Other NRXP SEC filings
Get alerts when NRXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days